Enforcement Report for Week of August 7, 2024
Endo Issues Voluntary Nationwide Recall of Clonazepam Tablets
Enforcement Report - Week of June 29, 2022
The U.S. Food and Drug Administration announced today in a Drug Safety Communication that it is requiring an update to the Boxed Warning, the agency’s most prominent safety warning, and requiring class-wide labeling changes for benzodiazepines to include the risks of abuse, misuse, addiction, physical dependence and withdrawal reactions to help improve their safe use.
New Delhi: Leading drug makers Lupin and Sun Pharma are recalling different products in the US, according to the US Food and Drug Administration (USFDA). The Mumbai-based drug maker Lupin is recalling 11,688 bottles of Lisinopril tablets USP, 10 mg, which is used to treat high blood pressure, in the US market, as per the latest Enforcement Report by the US health regulator.
FDA Commissioner K S Pannu said that late Tuesday, a raid was conducted at M/s Friends Medical Agency near the old bus stand in Faridkot district. Eleven types of addictive drugs, mostly Tramadol, Diphenoxylate and Buprenorphine and a total of 2,555 tablets were seized from the store.
The national drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 9 formulations under Drugs Prices Control Order (DPCO)- 2013 in related notification dated June 26, 2019.
ALEMBIC PHARMS LTD`s generic CLONAZEPAM Receives Approval in US
The percentage of outpatient medical visits that led to a benzodiazepine prescription doubled from 2003 to 2015, according to a study published Friday. And about half those prescriptions came from primary care physicians.